Immunocore Holdings Plc-adr (IMCR) Live Share Price, Invest From India

Immunocore Holdings Plc-adr Stock Performance

as on October 28, 2025 at 1:29 am IST

Day's Low
Day's High
$32.77
Day's Price Range
$34.18
$33.5
2.18%
Downside
2.03%
Upside
52 Week's Low
52 Week's High
$23.15
52-Week Price Range
$39.33
$33.5
30.90%
Downside
17.40%
Upside

Immunocore Holdings Plc-adr share price movements today

Previous Close: $33.10
Open: $33.72
Volume: 257.1K
Day's Low - High: $32.77 - $34.18
52 Week Low - High: $23.15 - $39.33

Immunocore Holdings Plc-adr Historical Returns

1 Month Return: -2.69 %
3 Month Return: -5.87 %
1 Year Return: + 0.93 %
3 Year Return: -41.08 %
5 Year Return: 0 %

Immunocore Holdings Plc-adr Stock Fundamentals & Key Indicators

Check Immunocore Holdings Plc-adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-0.641

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

8.22%

PE Ratio (TTM)

PEG Ratio

EBITDA

-24.6M

Revenue (TTM)

356.1M

Profit Margin

-5.70%

Return On Equity TTM

-5.43%

Immunocore Holdings Plc-adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunocore Holdings Plc-adr with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Immunocore Holdings Plc-adr	BUY	$1.7B	NA	NA	-5.70%
Alnylam Pharmaceuticals, Inc.	BUY	$60.7B	265.42%	-505.15	-12.96%
Beone Medicines Ltd	NA	$35.8B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$108.0B	98.59%	29.95	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$61.3B	-0.78%	14.55	31.37%

Stock Returns calculator for Immunocore Holdings Plc-adr Stock including INR - Dollar returns

The Immunocore Holdings Plc-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Immunocore Holdings Plc-adr investment value today

Current value as on today

₹1,07,209

Returns

₹7,209

(+7.21%)

Returns from Immunocore Holdings Plc-adr Stock

₹2,134 (+2.13%)

Dollar Returns*

₹5,074 (+5.07%)

Analyst Recommendation on Immunocore Holdings Plc-adr Stock

Based on 24 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 24 analysts, 91.67% of analysts recommend a 'BUY' rating for Immunocore Holdings Plc-adr. Average target price of $62.2

Immunocore Holdings Plc-adr Share Price Target

Get share price movements and forecasts by analysts on Immunocore Holdings Plc-adr.

What analysts predicted

46.14%UPSIDE

Target Price

$62.2

Current Price

$33.5

Analyzed by

24 Analysts

Target

$62.20

Immunocore Holdings Plc-adr target price $62.2, a slight upside of 46.14% compared to current price of $33.5. According to 24 analysts rating.

Immunocore Holdings Plc-adr Stock’s Investor Sentiment and Interest

Search interest for Immunocore Holdings Plc-adr Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 28, 2025 to October 28, 2025

Change:14% versus previous 30 day period

Immunocore Holdings Plc-adr Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	66	76	80	89	89	75	80	84	93	97
Gross Profit	66	74	80	134	89	73	79	83	93	96
Operating Income	-21	-19	-14	-17	-26	-16	-8	-19	-3	-14
EBITDA	-16	-14	3	-24	-19	-5	10	-16	9	-14
Interest Expense	1	1	1	1	3	4	4	6	3	3
Depreciation	1	1	1	0	1	0	1	1	0	0
Income Before Tax	-20	-17	0	-25	-24	-10	6	-24	6	-9
Income Tax Expense	0	0	0	-5	0	1	-2	-1	-1	0
Net Income	-25	-22	2	-25	-31	-11	8	-23	5	-10
Net Profit Margin	-37.49%	-29.47%	3.72%	-28.12%	-34.66%	-15.41%	10.89%	-28.28%	5.35%	-10.51%

Immunocore Holdings Plc-adr Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	29	33	40	35	174	315	310
Gross Profit	29	-97	-60	-62	174	314	307
Operating Income	-93	-118	-86	-129	-42	-59	-70
EBITDA	-86	-113	-82	-166	-38	-51	-38
Interest Expense	0	3	3	5	5	5	18
Depreciation	6	9	8	7	6	5	4
Income Before Tax	-88	-126	-87	-133	-33	-60	-52
Income Tax Expense	-16	-22	-13	0	9	-5	-1
Net Income	-90	-136	-99	-177	-63	-69	-51
Net Profit Margin	-302.82%	-404.89%	-246.04%	-493.45%	-36.55%	-22.17%	-16.47%

Immunocore Holdings Plc-adr Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-17	2	-33	-24	-11	8	-23	5	-10
Operating Cash Flow	-3	6	-16	-4	23	21	-13	0	25
Investing Cash Flow	3	2	0	0	-350	0	-3	9	-30
Financing Cash Flow	9	7	7	396	0	0	-51	2	3
Change in Cash	6	26	-1	390	-327	32	-82	21	11

Immunocore Holdings Plc-adr Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-48	-71	-103	-74	-133	-52	-43	-51
Operating Cash Flow	-60	-16	-101	-60	-105	-40	2	26
Investing Cash Flow	-9	58	-4	0	0	0	-5	-355
Financing Cash Flow	19	0	55	115	276	138	34	343
Change in Cash	-51	41	-50	55	146	114	40	13

Global Institutional Holdings in Immunocore Holdings Plc-adr

Funds	Holdings
T. Rowe Price Investment Management,Inc.	14.07%
RTW INVESTMENTS, LLC	9.69%
FMR Inc	9.67%
Wellington Management Company LLP	8.39%
PRIMECAP Management Company	7.51%

See all

Insights on Immunocore Holdings Plc-adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 6 quarters, 70.50M → 97.96M (in $), with an average increase of 6.3% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.9% return, outperforming this stock by 180.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 61.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, IMCR stock has moved down by -2.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 5.02M → -10.3M (in $), with an average decrease of 305.1% per quarter

About Immunocore Holdings Plc-adr

immunocore is a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. its world-leading t cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells. immunocore has established a robust technology platform which combines monoclonal t cell receptor (mtcr) targeting technology with an effector technology, anti-cd3 scfv, that catalyses the killing of the targeted diseased cells by the host’s own non-specific cytotoxic t cells. immunocore is developing a portfolio of products from the platform, called immtacs, for the treatment of cancer, chronic infectious disease and diabetes.

Organisation	Immunocore Holdings Plc-adr
Headquarters	92 Park Drive, Abingdon, United Kingdom, OX14 4RY
Industry	Services
CEO	Dr. Bahija Jallal Ph.D.
E-voting on shares	Click here to vote

Key Management of Immunocore Holdings Plc-adr

Name	Title
Mr. Clayton Robertson	Head of Investor Relations
Ms. Lily Margaret Hepworth	Executive VP, General Counsel & Company Secretary
Ms. Tina St. Leger	Executive VP & Chief Human Resources Officer
Dr. David Berman M.D., Ph.D.	Executive Vice President of Research & Development
Mr. John Trainer M.B.A.	SVP & Chief Operating Officer
Mr. John Goll III	SVP, Finance & Chief Accounting Officer
Mr. Sean D. Buckley	VP & Chief Information Officer
Dr. Bahija Jallal Ph.D.	CEO & Executive Director
Mr. Travis A. Coy	CFO, Executive VP & Head of Corporate Development
Ms. Annelise Vuidepot Ph.D.	Senior VP, CTO and Research & UK Site Lead

FAQs

What is Immunocore Holdings Plc-adr share price today?

Immunocore Holdings Plc-adr share price today is $33.5 as on October 28, 2025 at 1:29 am IST at the close of the market. Immunocore Holdings Plc-adr share today touched a day high of $34.18 and a low of $32.77.

What is the 52 week high and 52 week low for Immunocore Holdings Plc-adr share?

Immunocore Holdings Plc-adr share touched a 52 week high of $39.33 on June 4, 2025 and a 52 week low of $23.15 on April 9, 2025. Immunocore Holdings Plc-adr stock price today i.e. October 28, 2025 at 1:29 am IST is closed at $33.5,which is 14.82% down from its 52 week high and 44.71% up from its 52 week low.

What is Immunocore Holdings Plc-adr's market capitalisation today?

Immunocore Holdings Plc-adr market capitalisation is $0.00T as on October 28, 2025 at 1:29 am IST.

How to invest in Immunocore Holdings Plc-adr Stock (IMCR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Immunocore Holdings Plc-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunocore Holdings Plc-adr Shares that will get you 0.0448 shares as per Immunocore Holdings Plc-adr share price of $33.5 per share as on October 28, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immunocore Holdings Plc-adr Stock (IMCR) from India?

Indian investors can start investing in Immunocore Holdings Plc-adr (IMCR) shares with as little as ₹88.189 or $1 (as of October 28, 2025 at 2:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.89 in Immunocore Holdings Plc-adr stock (as per the Rupee-Dollar exchange rate as on October 28, 2025 at 2:41 am IST). Based on Immunocore Holdings Plc-adr share’s latest price of $33.5 as on October 28, 2025 at 1:29 am IST, you will get 0.2985 shares of Immunocore Holdings Plc-adr. Learn more about fractional shares .